Matthew L. Trerotola Enovis Corp (ENOV) insider trading activity

Matthew L. Trerotola is CEO of Enovis CORP. Currently has a direct ownership of 270,074 shares of ENOV, which is worth approximately $12 Million. The most recent transaction as insider was on Mar 06, 2024, when has been sold 6,157 shares (Common Stock, par value $0.001) at a price of $61.84 per share, resulting in proceeds of $380,748. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 270K

0% 3M change

36.82% 12M change

Total Value Held $12 Million

Matthew L. Trerotola Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 06 2024	SELL Payment of exercise price or tax liability	$380,748 $61.84 p/Share	6,157 Reduced 2.23%	270,074 Common Stock, par valu...
Mar 04 2024	BUY Grant, award, or other acquisition	-	64,484 Added 18.93%	276,231 Common Stock, par valu...
Mar 01 2024	SELL Payment of exercise price or tax liability	$258,319 $59.81 p/Share	4,319 Reduced 2.0%	211,747 Common Stock, par valu...
Feb 23 2024	SELL Payment of exercise price or tax liability	$1,480,989 $63.8 p/Share	23,213 Reduced 9.7%	216,066 Common Stock, par valu...
Feb 22 2024	BUY Grant, award, or other acquisition	-	45,635 Added 16.02%	239,279 Common Stock, par valu...
Feb 20 2024	SELL Payment of exercise price or tax liability	$204,194 $59.29 p/Share	3,444 Reduced 1.74%	193,944 Common Stock, par valu...
Mar 06 2023	SELL Open market or private sale	$389,003 $57.69 p/Share	6,743 Reduced 3.3%	197,388 Common Stock, par valu...
Feb 28 2023	BUY Grant, award, or other acquisition	-	28,221 Added 12.15%	204,131 Common Stock, par valu...
Feb 27 2023	SELL Open market or private sale	$1,063,324 $56.21 p/Share	18,917 Reduced 9.71%	175,910 Common Stock, par valu...
Feb 27 2023	BUY Grant, award, or other acquisition	-	32,283 Added 14.21%	194,827 Common Stock, par valu...
Feb 23 2023	SELL Open market or private sale	$215,475 $54.62 p/Share	3,945 Reduced 2.37%	162,544 Common Stock, par valu...
Feb 21 2023	SELL Open market or private sale	$234,775 $62.11 p/Share	3,780 Reduced 2.22%	166,489 Common Stock, par valu...
Mar 07 2022	SELL Open market or private sale	$466,638 $38.88 p/Share	12,002 Reduced 2.82%	413,524 Common stock, par valu...
Feb 28 2022	SELL Open market or private sale	$4,068,723 $41.07 p/Share	99,068 Reduced 18.88%	425,526 Common stock, par valu...
Feb 25 2022	BUY Grant, award, or other acquisition	-	185,067 Added 26.08%	524,594 Common stock, par valu...
Feb 23 2022	SELL Open market or private sale	$270,431 $41.83 p/Share	6,465 Reduced 1.87%	339,527 Common stock, par valu...
Feb 17 2022	BUY Grant, award, or other acquisition	-	40,284 Added 10.43%	345,992 Common stock, par valu...
Nov 08 2021	SELL Open market or private sale	$2,671,000 $53.42 p/Share	50,000 Reduced 14.06%	305,708 Common stock, par valu...
Nov 08 2021	BUY Exercise of conversion of derivative security	$1,977,000 $39.54 p/Share	50,000 Added 12.32%	355,708 Common stock, par valu...
Oct 15 2021	SELL Open market or private sale	$2,537,500 $50.75 p/Share	50,000 Reduced 14.06%	305,708 Common stock, par valu...
Oct 15 2021	BUY Exercise of conversion of derivative security	$1,977,000 $39.54 p/Share	50,000 Added 12.32%	355,708 Common stock, par valu...
Sep 13 2021	SELL Open market or private sale	$2,779,210 $46.66 p/Share	59,563 Reduced 16.31%	305,708 Common stock, par valu...
Sep 13 2021	BUY Exercise of conversion of derivative security	$1,414,026 $23.74 p/Share	59,563 Added 14.02%	365,271 Common stock, par valu...
Aug 16 2021	SELL Open market or private sale	$7,464,773 $49.29 p/Share	151,446 Reduced 33.13%	305,708 Common stock, par valu...
Aug 16 2021	BUY Exercise of conversion of derivative security	$4,791,751 $31.64 p/Share	151,446 Added 24.88%	457,154 Common stock, par valu...

Also insider at

ATR

APTARGROUP, INC. Healthcare

Director

MLT